PL357550A1 - Nowa postać galenowa molsydominy do podawania doustnego, o przedłużonym uwalnianiu - Google Patents

Nowa postać galenowa molsydominy do podawania doustnego, o przedłużonym uwalnianiu

Info

Publication number
PL357550A1
PL357550A1 PL01357550A PL35755001A PL357550A1 PL 357550 A1 PL357550 A1 PL 357550A1 PL 01357550 A PL01357550 A PL 01357550A PL 35755001 A PL35755001 A PL 35755001A PL 357550 A1 PL357550 A1 PL 357550A1
Authority
PL
Poland
Prior art keywords
molsidomine
hours
released
angina
galenical form
Prior art date
Application number
PL01357550A
Other languages
English (en)
Other versions
PL201631B1 (pl
Inventor
Jozsef-Michel Geczy
Original Assignee
Therabel Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therabel Pharmaceuticals Limited filed Critical Therabel Pharmaceuticals Limited
Publication of PL357550A1 publication Critical patent/PL357550A1/pl
Publication of PL201631B1 publication Critical patent/PL201631B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL357550A 2000-02-24 2001-02-22 Doustny preparat galenowy molsydominy w postaci stałej o przedłużonym uwalnianiu PL201631B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0002307A FR2805462B1 (fr) 2000-02-24 2000-02-24 Nouvelle forme galenique orale a liberation prolongee de la molsidomine
PCT/EP2001/002055 WO2001062256A1 (fr) 2000-02-24 2001-02-22 Nouvelle forme galenique orale a liberation prolongee de la molsidomine

Publications (2)

Publication Number Publication Date
PL357550A1 true PL357550A1 (pl) 2004-07-26
PL201631B1 PL201631B1 (pl) 2009-04-30

Family

ID=8847342

Family Applications (1)

Application Number Title Priority Date Filing Date
PL357550A PL201631B1 (pl) 2000-02-24 2001-02-22 Doustny preparat galenowy molsydominy w postaci stałej o przedłużonym uwalnianiu

Country Status (36)

Country Link
US (1) US7767227B2 (pl)
EP (1) EP1265614B1 (pl)
JP (1) JP4945043B2 (pl)
KR (1) KR100814191B1 (pl)
CN (1) CN100396284C (pl)
AT (1) ATE296632T1 (pl)
AU (2) AU4065301A (pl)
BE (1) BE1013487A3 (pl)
BG (1) BG66111B1 (pl)
BR (1) BRPI0108041B8 (pl)
CA (1) CA2400886C (pl)
CZ (1) CZ301993B6 (pl)
DE (1) DE60111196T2 (pl)
DZ (1) DZ3273A1 (pl)
EE (1) EE05098B1 (pl)
ES (1) ES2241803T3 (pl)
FR (1) FR2805462B1 (pl)
HK (1) HK1050138B (pl)
HR (1) HRP20020692B1 (pl)
HU (1) HU229799B1 (pl)
IL (2) IL151205A0 (pl)
IS (1) IS2446B (pl)
MA (1) MA25576A1 (pl)
MD (1) MD3119C2 (pl)
MX (1) MXPA02008262A (pl)
NO (1) NO329495B1 (pl)
NZ (1) NZ520691A (pl)
OA (1) OA12183A (pl)
PL (1) PL201631B1 (pl)
PT (1) PT1265614E (pl)
RS (1) RS50291B (pl)
RU (1) RU2263506C2 (pl)
SK (1) SK286313B6 (pl)
UA (1) UA73972C2 (pl)
WO (1) WO2001062256A1 (pl)
ZA (1) ZA200206042B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
US7803402B2 (en) * 2002-07-06 2010-09-28 Sanjeev Khandelwal Pharmaceutical preparations
FR2868314B1 (fr) * 2004-04-05 2008-10-24 Therabel Pharmaceuticals Ltd Nouvelle utilisation therapeutique de la molsidomine et de ses sels pharmaceutiquement acceptables
EP2468269A1 (en) 2010-11-26 2012-06-27 Universitätsklinikum Münster Nitric oxide donors in therapy of nitric oxide deficiency-induced disturbances of cerebral microcirculation
BE1028879B1 (fr) 2020-12-11 2022-07-12 Europharmaceuticals Comprimé à libération prolongée de la molsidomine

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3522191A1 (de) * 1985-06-21 1987-01-15 Cassella Ag Photostabilisierung von sydnoniminen
CN1006522B (zh) * 1986-04-30 1990-01-24 田道制药有限公司 缓放性制剂的制备方法
JP3078859B2 (ja) * 1990-02-23 2000-08-21 武田薬品工業株式会社 安定な放出制御性製剤用コーティング剤
HU211648A9 (en) * 1990-03-28 1995-12-28 Chinoin Gyogyszer Es Vegyeszet Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
HU210921B (en) * 1990-03-28 1995-09-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
DE4140192C2 (de) * 1991-12-05 1996-02-29 Alfatec Pharma Gmbh Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
EP0624370B1 (de) * 1993-05-11 1999-10-06 Hoechst Aktiengesellschaft Galenische Zubereitungen von Molsidomin
JPH09503997A (ja) * 1993-07-08 1997-04-22 シグナス,インコーポレイテッド モノリシックなマトリックス経皮送達システム
IT1266565B1 (it) * 1993-07-22 1997-01-09 Ct Lab Farm Srl Composizioni farmaceutiche a rilascio controllato a base di uno o piu' sali farmaceuticamente accettabili dell'acido gamma-idrossi-butirrico.
HU218280B (en) * 1994-04-26 2000-07-28 Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes
DE4443105C2 (de) * 1994-12-03 1997-03-13 Hoechst Ag Verfahren zur Herstellung Molsidomin-haltiger Tabletten
JPH09114680A (ja) * 1995-10-19 1997-05-02 Fuji Xerox Co Ltd シーケンス制御装置
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
EP1028712B1 (en) * 1997-09-19 2005-01-12 Shire Laboratories Inc. Solid solution beadlet
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine

Also Published As

Publication number Publication date
CA2400886A1 (fr) 2001-08-30
FR2805462B1 (fr) 2003-08-15
BR0108041B1 (pt) 2013-06-18
EP1265614B1 (fr) 2005-06-01
NO20024043D0 (no) 2002-08-23
MD3119B2 (en) 2006-08-31
HRP20020692A2 (en) 2004-02-29
SK12202002A3 (sk) 2002-12-03
BE1013487A3 (fr) 2002-02-05
SK286313B6 (en) 2008-07-07
PT1265614E (pt) 2005-10-31
HUP0300607A3 (en) 2006-02-28
IL151205A (en) 2011-01-31
BR0108041A (pt) 2002-10-29
DZ3273A1 (fr) 2001-08-30
YU62202A (sh) 2006-01-16
CN100396284C (zh) 2008-06-25
US20030045522A1 (en) 2003-03-06
AU4065301A (en) 2001-09-03
NZ520691A (en) 2004-07-30
AU2001240653B2 (en) 2005-05-26
EP1265614A1 (fr) 2002-12-18
RU2263506C2 (ru) 2005-11-10
OA12183A (fr) 2006-05-09
CZ301993B6 (cs) 2010-09-01
IL151205A0 (en) 2003-04-10
MXPA02008262A (es) 2004-04-05
BRPI0108041B8 (pt) 2021-05-25
NO20024043L (no) 2002-08-23
KR100814191B1 (ko) 2008-03-17
FR2805462A1 (fr) 2001-08-31
AU2001240653B9 (en) 2005-10-27
JP2003523981A (ja) 2003-08-12
WO2001062256A1 (fr) 2001-08-30
MA25576A1 (fr) 2002-10-01
PL201631B1 (pl) 2009-04-30
ZA200206042B (en) 2003-07-29
ATE296632T1 (de) 2005-06-15
KR20020081323A (ko) 2002-10-26
MD3119C2 (ro) 2007-04-30
HRP20020692B1 (en) 2011-10-31
CN1419451A (zh) 2003-05-21
MD20020212A (en) 2002-12-31
UA73972C2 (en) 2005-10-17
DE60111196T2 (de) 2006-05-11
CA2400886C (fr) 2011-04-19
US7767227B2 (en) 2010-08-03
HUP0300607A2 (hu) 2003-08-28
HU229799B1 (en) 2014-07-28
JP4945043B2 (ja) 2012-06-06
ES2241803T3 (es) 2005-11-01
IS2446B (is) 2008-11-15
IS6504A (is) 2002-08-14
BG66111B1 (bg) 2011-05-31
HK1050138A1 (en) 2003-06-13
EE05098B1 (et) 2008-12-15
DE60111196D1 (de) 2005-07-07
NO329495B1 (no) 2010-11-01
BG107027A (bg) 2003-04-30
EE200200472A (et) 2003-12-15
RS50291B (sr) 2009-09-08
RU2002121503A (ru) 2004-03-20
HK1050138B (zh) 2005-07-29

Similar Documents

Publication Publication Date Title
MY142204A (en) Pramipexole once-daily dosage form
RU2005115855A (ru) Композиция трамадола продлонгированного высвобождением с 24-часовым действием
ATE333265T1 (de) Oral anzuwendende schnell zerfallende feste darreichungsformen
CA2476201A1 (en) Modified release formulations of at least one form of tramadol
MY126555A (en) Oral pharmaceutical extended release dosage form
MX2009001711A (es) Formulaciones de liberacion sostenida de topiramato.
MX2008000099A (es) Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones.
EA200870368A1 (ru) Антибиотические композиции с модифицированным высвобождением и способ их получения
GB2395434A (en) Composition for reducing appetite in mammals comprising proxyanidin
WO2003005967A3 (en) Dual release levodopa ethyl ester and decarboxylase in controlled release core
CA2415154A1 (en) Modified release formulations of selective serotonin re-uptake inhibitors
HRP20020692A2 (en) Novel galenical form for oral administration with prolonged release of molsidomine
WO2007010559A3 (en) Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor
MXPA05008843A (es) Sistema terapeutico que comprende amoxicilina y acido clavulanico.
JP2004522780A5 (pl)
ITMI20080798A1 (it) Composizione a rilascio modificato a base di doxofillina
IT1293835B1 (it) Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione
NO20032581L (no) Farmasöytisk formulering av gepiron for oral administrering
HRP20160479T1 (hr) Oralni pripravak molsidomina s produljenim otpuštanjem, namijenjen liječenju ateroskleroze
NZ521515A (en) Composition comprising paracetamol and niflumic acid